0001213900-23-041960.txt : 20230522 0001213900-23-041960.hdr.sgml : 20230522 20230522160127 ACCESSION NUMBER: 0001213900-23-041960 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230518 FILED AS OF DATE: 20230522 DATE AS OF CHANGE: 20230522 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Oron Assaf CENTRAL INDEX KEY: 0001792310 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38762 FILM NUMBER: 23944339 MAIL ADDRESS: STREET 1: C/O BIOMX LTD. STREET 2: 7 PINHAS SAPIR ST., FLOOR 2 CITY: NESS ZIONA STATE: L3 ZIP: 7414002 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BiomX Inc. CENTRAL INDEX KEY: 0001739174 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 22 EINSTEIN ST., 4TH FLOOR CITY: NESS ZIONA STATE: L3 ZIP: 7414003 BUSINESS PHONE: (972) 72 394 2377 MAIL ADDRESS: STREET 1: 22 EINSTEIN ST., 4TH FLOOR CITY: NESS ZIONA STATE: L3 ZIP: 7414003 FORMER COMPANY: FORMER CONFORMED NAME: Chardan Healthcare Acquisition Corp. DATE OF NAME CHANGE: 20180430 4 1 ownership.xml X0407 4 2023-05-18 0 0001739174 BiomX Inc. PHGE 0001792310 Oron Assaf C/O BIOMX INC. 22 EINSTEIN ST., FLOOR 4 NESS ZIONA L3 7414003 ISRAEL 0 1 0 0 Chief Business Officer 0 Common Stock 2023-05-18 4 P 0 1201 0.2727 A 1201 D Common Stock 2023-05-19 4 P 0 6521 0.2809 A 7722 D The price reported in Column 4 is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $0.2701 to $0.2750, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the above range. The price reported in Column 4 is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $0.2752 to $0.2898, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the above range. /s/ Assaf Oron 2023-05-22